Primer on Tumor Immunology and Cancer Immunotherapy™ Schedule

Thursday, Nov. 9

8 – 8:05 a.m.          Welcome and Introductions
Nina Bhardwaj, MD, PhD – The Tisch Cancer Institute at The Mount Sinai Medical Center

Session I: Basic Immunology – A Brief Overview

8:05 – 8:35 a.m. Innate Lymphocytes
Amir Horowitz, PhD –Icahn School of Medicine at Mount Sinai
8:35 – 9:05 a.m. Monocytes and Macrophages in Cancer
Vincenzo Bronte, MD University of Verona
9:05 – 9:35 a.m. Dendritic Cells and Antigen Presentation
A. Karolina Palucka, MD, PhD – The Jackson Laboratory for Genomic Medicine
9:35 – 10:05 a.m. Adaptive Immunity
Jonathan Powell, MD, PhD – Johns Hopkins University School of Medicine
10:05 – 10:20 a.m. Panel Questions and Answers
10:20 – 10:35 a.m. Break

Session II: Treating Tumors with Passive Immunotherapy

10:35 – 10:40 a.m.        Session II Introduction
Nina Bhardwaj, MD, PhD – The Tisch Cancer Institute at The Mount Sinai Medical Center
10:40 – 11:10 a.m. Cytokines: Interferons, Interleukins and Beyond 
Jeffrey S. Miller, MD – University of Minnesota
11:10 – 11:40 a.m. Adoptive T Cell Therapy
Cassian Yee, MD – University of Texas MD Anderson Cancer Center
11:40 a.m. – 12:10 p.m. Monoclonal Antibodies and Bi-Specifics/Structure and Mechanism of Action
Charles G. Drake, MD, PhD – Columbia University Medical Center
12:10 – 12:25 p.m.         Panel Questions and Answers 
12:30 – 1:30 p.m. Lunch

Session III: Active Immunotherapy: Unleashing the Patient’s Own Immune System

1:30 – 1:35 p.m. Session III Introduction
Timothy N.J. Bullock, PhD – University of Virginia
1:35 – 2:05 p.m. Targeting Regulatory Molecules in Cancer Therapy: New Insights and Opportunities
Michael A. Curran, PhD – University of Texas MD Anderson Cancer Center
2:05 – 2:35 p.m. Cancer Vaccines
Ross Kedl, PhD – University of Colorado School of Medicine
2:35 – 2:50 p.m. Panel Questions and Answers
2:50 – 3:05 p.m. Break

Session IV: Immune Monitoring: Figuring out How it All Works

3:05 – 3:10 p.m. Session IV Introduction
Timothy N.J. Bullock, PhD – University of Virginia
3:10 – 3:40 p.m. Immune Monitoring and Next Generation
Sacha Gnjatic, PhD – Ican School of Medicine at Mount Sinai
3:40 – 4:10 p.m. On The Horizon: IO Combinations
Jeffrey Sosman, MD – Northwestern University
4:10 – 4:40 p.m. Biomarkers – Mutational Load
Timothy A. Chan, MD, PhD – Memorial Sloan Kettering Cancer Center 
4:40 – 4:55 p.m. Panel Questions and Answers
4:55 – 5 p.m. Closing Remarks
Timothy N.J. Bullock, PhD – University of Virginia